Kyle Diamantas remains acting FDA commissioner beyond 2027-01-15
user-generated· leadership
Kyle Diamantas remains acting FDA commissioner beyond 2027-01-15
Market overview
Diamantas' appointment as acting commissioner lacks broad political support, but no credible alternative emerges quickly. Institutional inertia and the 2024 election cycle will prolong his tenure.
leadership prediction market
- Implied probability (Yes)
- 60%
- Closes
- 2027-12-31
Source: user-generated
More leadership markets
- Will CFO resign before 2026-12-31? — 40% Yes
- Rep. Edwards resigns from Congress before 2026 midterms — 55% Yes
- Chuck Edwards to resign before Ethics Committee ruling — 70% Yes
- Witkoff Rubio partnership gains influence in Middle East policy by 2027 — 55% Yes
- Edwards resigns from Congress by end of 2028 — 60% Yes
- Trump administration to nominate a more industry-aligned FDA chief by Labor Day — 68% Yes
- NRCC chair calls for town halls ban by 2027 — 60% Yes
- Will CEO Mark Zediker resign before FYE? — 60% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…